Interaction between proton pump inhibitors and clopidogrel
Introduction: Proton pump inhibitors (PPI) may impair the biotransformation of clopidogrel leading to increased major adverse cardiac events (MACE). Available studies have focused solely on patients receiving clopidogrel following a cardiac event. Given the widespread use of this combination, (about...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
2011
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/2152/ETD-UT-2010-08-1550 |